Tony Fong

Managing Editor, 360Dx

Phone

+1-212-651-5635

Email

[email protected]

Tony Fong is managing editor for 360Dx, GenomeWeb's news site on the in vitro diagnostics market.

Articles Authored by Tony Fong

May 30, 2017

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer
Premium

Winship's director of the cancer tissue and pathology shared resource said that some labs aren't leveraging molecular technologies due to reimbursement issues.

Tony Fong

Articles Authored by Tony Fong

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer
Premium

Abbisko Therapeutics Launches Phase I Trial of FGFR2/3 Inhibitor for Solid Tumors

Structural Variant Study Points to Pediatric Glioma Drivers, Prognostic Features

Zenith Epigenetics to Explore BET Inhibitor Combinations in Multiple NCI-Sponsored Trials

Turnstone, Moffitt Cancer Center Get FDA Permission to Study TIL Therapy in Melanoma Patients

Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China

Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition

Tony Fong

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer Premium

Abbisko Therapeutics Launches Phase I Trial of FGFR2/3 Inhibitor for Solid Tumors

Structural Variant Study Points to Pediatric Glioma Drivers, Prognostic Features

Zenith Epigenetics to Explore BET Inhibitor Combinations in Multiple NCI-Sponsored Trials

Turnstone, Moffitt Cancer Center Get FDA Permission to Study TIL Therapy in Melanoma Patients

Guardant Health Licenses Genomic Cancer Assays to Adicon for Testing in China

Bio-Techne Nabs CE Mark for HPV Head and Neck Cancer Test, Completes Namocell Acquisition

Q&A: Winship Cancer Institute's Dan Brat on the Challenges of Using MDx for Cancer
Premium